MINNEAPOLIS
--(BUSINESS WIRE)--Jan. 23, 2018--
Piper Jaffray Companies
(NYSE: PJC), a leading investment bank and asset management firm, is pleased to announce the hiring of
Tyler Van Buren
as a senior research analyst responsible for covering biotechnology companies. He will be based in the firm’s
New York
office.
In 2017,
Institutional Investor
recognized
Van Buren
as the
No. 1
Rising Star in the specialty pharma category and the No. 2 Rising Star across therapeutics. He joins
Piper Jaffray
from
Cowen and Company
, where he was an equity research analyst covering large and smid-cap biopharma companies for five years. Prior to that,
Van Buren
was a founding member and managing director at
New York
-based
LifeSci Advisors
, where he helped build the firm’s biotechnology research practice. Earlier in his career, he worked at
Amylin Pharmaceuticals
,
Lithera Pharmaceuticals
, the
Sanford-Burnham Medical Research Institute
and the
U.S. Department of Agriculture
.
“Tyler brings a breadth of both industry and sell-side experience across biopharma, biotech and the broader healthcare space. This addition will add strength to our firm’s overall leadership in the healthcare sector and add immediate value for our clients,” said
Michael Cox
, director of equity research at
Piper Jaffray
.
Van Buren
earned a master’s degree in biology and a bachelor’s degree in biochemistry and cellular biology from the
University of California, San Diego
.
The
Piper Jaffray
equity research group consists of
40 senior analysts
covering
680 companies
across the following sectors: consumer, energy, financial services, healthcare, industrials & business services, and technology.
About
Piper Jaffray
Piper Jaffray Companies
(NYSE: PJC) is a leading investment bank and asset management firm. Securities brokerage and investment banking services are offered in the U.S. through
Piper Jaffray & Co.
, member
SIPC
and FINRA; in
Europe
through
Piper Jaffray Ltd.
and
Simmons & Company International Limited
, authorized and regulated by the
U.K. Financial Conduct Authority
; and in
Hong Kong
through
Piper Jaffray Hong Kong Limited
, authorized and regulated by the
Securities and Futures Commission
. Asset management products and services are offered through five separate investment advisory affiliates―U.S. Securities and Exchange Commission (
SEC
) registered
Advisory Research, Inc.
;
Piper Jaffray Investment Management LLC
,
PJC Capital Partners LLC
and
Piper Jaffray & Co.
; and Guernsey-based
Parallel General Partners Limited
, authorized and regulated by the
Guernsey Financial Services Commission
.
Follow
Piper Jaffray
:
LinkedIn
|
Facebook
|
Twitter
© 2018
Piper Jaffray Companies
, 800 Nicollet Mall, Suite 1000,
Minneapolis, Minnesota
55402-7036
View source version on businesswire.com:
http://www.businesswire.com/news/home/20180123006575/en/
Source:
Piper Jaffray Companies
Piper Jaffray Companies
Pamela Steensland, 612-303-8185
analystmediarelations@pjc.com
